Table 1.
Patient characteristic and status before DC vaccination (HCC hepatocellular carcinoma, CCC cholangiocellular carcinoma; LC liver cirrhosis, CH chronic hepatitis; HBV hepatitis B virus positive, HCV hepatitis C virus positive; TAI transarterial injection, TAE transarterial embolization, MCT microwave coagulation therapy, PEI percutaneous ethanol injection, RFA radiofrequency ablation)
| Patient | Age (years) | Sex | Diagnosis | Background liver | Metastasis | Previous therapies |
|---|---|---|---|---|---|---|
| 1 | 64 | M | HCC | LC (HCV) | Bone | TAI, MCT, radiation |
| 2 | 48 | M | CCC | Normal | – | – |
| 3 | 70 | M | HCC | LC (HBV) | – | TAI |
| 4 | 65 | M | HCC | LC (HCV) | Lung | TAI, TAE, PEI, hepatectomy |
| 5 | 54 | M | HCC | CH (HBV) | – | TAI |
| 6 | 65 | M | HCC | CH (HBV) | – | TAI, chemotherapy |
| 7 | 63 | M | HCC | LC (virus-free) | – | Hepatectomy, TAI, TAE |
| 8 | 83 | F | CCC | Normal | – | Hepatectomy, TAI, Chemotherapy |
| 9 | 75 | F | HCC | LC (HCV) | – | TAI, TAE, PEI, RFA |
| 10 | 63 | M | HCC | LC (HCV) | Bone, adrenal gland | Hepatectomy, Chemotherapy |